email@example.com @CDomenech_Aph Contact Person Mr. Carles Domenech, CEO Products/Services AbilityPharma is a clinical-stage biopharma company focused on developing first-in-class drugs causing autophagy by TRIB3 overexpression and inhibition of the PI3K/Akt/mTOR pathway, to treat multiple cancers. ABTL0812 completed the phase 1/1b clinical trial with excellent safety and efficacy signals. The phase 2 started in Sept 2016 for sqNSCLC and endometrial cancer as first-line therapy, in top institutions in Spain and France. Orphan statuts granted for neuroblastoma and pancreatic cancer. Trademarks ABTL0812.
ALTA LIFE SCIENCES
firstname.lastname@example.org @montsevendrell Contact Person Mrs. Montserrat Vendrell Products/Services Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health. Alta LS is a bridge fund, connecting both sides of the Atlantic, joining the Spanish life sciences ecosystem with the Venture Capital expertise of Silicon Valley.